Hardcover. Zustand: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.
Hardcover. Zustand: Fine. Gebrochener Buchrücken / Seiten oder Softcover umgeknickt. This book summarizes the current research on the efficacy and safety of Ticlopidine as an agent for preventing stroke.
Verlag: Saunders, PA, 1979
Anbieter: Between the Covers-Rare Books, Inc. ABAA, Gloucester City, NJ, USA
Erstausgabe
Hardcover. Zustand: Fine. First edition. Fine.
Hardcover. Zustand: Near Fine. No Jacket. 3rd. shelf wear on the boards. internally clean and soundly bound. near fine copy. [SK]. Our orders are shipped using tracked courier delivery services.
Sprache: Englisch
Verlag: Springer-Verlag, New York, 1993
ISBN 10: 038794009X ISBN 13: 9780387940090
Anbieter: PsychoBabel & Skoob Books, Didcot, Vereinigtes Königreich
EUR 56,92
Anzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: Very Good. Hardcover (no jacket; printed boards). Very good condition. With 20 illustrations. A few minor scuffs to extremities of boards. Pages are sound and clear. TA. Used.
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 61,52
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 77,63
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. reprint edition. 162 pages. 9.25x6.10x0.40 inches. In Stock.
EUR 48,37
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 92,84
Anzahl: 1 verfügbar
In den WarenkorbZustand: Used.
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: Used.
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Blood platelets lack a nucleus. As a result their life span is short and they cannot reproduce themselves. Platelets share these qualities with the red blood cell. Plate lets and red blood cells, nevertheless, serve vital roles in the body. One major function of the platelet is its capacity to aggregate and thereby initiate intravas cular coagulation which often underlies such major diseases as myocardial infarc tion, cerebral infarction, and pulmonary embolism. For this reason in recent years, medical attention has been directed to drugs that inhibit platelet aggregation. Aspirin was the first drug to be proven effective in this area. Since then other drugs that share aspirin's fundamental biochemical action, inhibition of platelet cyclooxygenase, have also been studied. Very recently, ticlopidine, the first of what promises to be a new class of drugs inhibiting platelet aggregation and coagulation via an entirely different biochemical mechanism, has been exten sively studied and clinically shown to be as effective or more effective than aspirin in the prevention of ischemic cardiovascular and cerebrovascular disease.